Ronny Drapkin, Incoming President and CEO at The Wistar Institute, shared on X:
“Incredible session at the 2026 DOD Ovarian Cancer Academy retreat Penn Medicine Cancer with the pioneer of CAR T-cell therapy, Carl June!
Thank you for sharing your groundbreaking work and showing us how AI is transforming the search for better targets.”
Other articles from Carl June on OncoDaily.